Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3209 participants.
Also called NCT03310125
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 3,209 participants
- Registry
-
NCT03310125
-
- Main results
- Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Canada, Colombia, Hong Kong SAR China, Italy, Malaysia, Pakistan, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03310125. Randomized; quadruple masking; primary purpose prevention. Start 2018-02-14 (actual); primary completion 2023-06-01 (actual). Results posted on 2026-10-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
- Acronym
- COP-AF
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Condition
- Myocardial Injury After Non-Cardiac Surgery
- Intervention (Drug)
- Active Colchicine
- Intervention (Drug)
- Active Placebo
- Lead sponsor
- Population Health Research Institute
- Collaborator
- Hamilton Health Sciences Corporation
Record details
- Record id
cardio:ct-nct03310125- Content hash
afdf2fde17430e1b81512b9ededa4183f1c480b3bebeaa42ad4de155c4b2c367